 | Up a level |
Riek, Myriam; Scherer, Almut; Möller, Burkhard; Ciurea, Adrian; von Mühlenen, Ines; Gabay, Cem; Kyburz, Diego; Brulhart, Laure; von Kempis, Johannes; Mueller, Ruediger B; Hasler, Paul; Strahm, Tanja; von Känel, Sabine; Zufferey, Pascal; Dudler, Jean; Finckh, Axel (2023). Serious infection risk of tofacitinib compared to biologics in patients with rheumatoid arthritis treated in routine clinical care. Scientific Reports, 13(1), p. 17776. Nature Publishing Group 10.1038/s41598-023-44841-w
Raptis, Catherine E; Berger, Christoph T; Ciurea, Adrian; Andrey, Diego O; Polysopoulos, Christos; Lescuyer, Pierre; Maletic, Tanja; Riek, Myriam; Scherer, Almut; von Loga, Isabell; Safford, Judith; Lauper, Kim; Möller, Burkhard; Vuilleumier, Nicolas; Finckh, Axel; Rubbert-Roth, Andrea (2022). Type of mRNA COVID-19 vaccine and immunomodulatory treatment influence humoral immunogenicity in patients with inflammatory rheumatic diseases. Frontiers in immunology, 13(1016927), p. 1016927. Frontiers Research Foundation 10.3389/fimmu.2022.1016927
